Barish Edil to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications Barish Edil has written about Carcinoma, Pancreatic Ductal.
Connection Strength
2.590
-
Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2017 Feb; 24(2):560.
Score: 0.486
-
Diffuse replacement of pancreatic parenchyma by intraductal papillary mucinous neoplasm. Endoscopy. 2013; 45 Suppl 2 UCTN:E407-9.
Score: 0.401
-
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Lett. 2022 07 28; 539:215722.
Score: 0.180
-
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma. Clin Cancer Res. 2021 03 01; 27(5):1278-1286.
Score: 0.163
-
Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2015 Aug; 150(8):701-10.
Score: 0.113
-
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors. J Immunother. 2015 Jan; 38(1):1-11.
Score: 0.108
-
Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1574-9.
Score: 0.108
-
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):458-9.
Score: 0.100
-
Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S725-30.
Score: 0.099
-
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
Score: 0.098
-
Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT. AJR Am J Roentgenol. 2013 Mar; 200(3):563-9.
Score: 0.095
-
Young patients undergoing resection of pancreatic cancer fare better than their older counterparts. J Gastrointest Surg. 2013 Feb; 17(2):339-44.
Score: 0.094
-
Vaccines for pancreatic cancer. Cancer J. 2012 Nov-Dec; 18(6):642-52.
Score: 0.093
-
Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases. Am J Surg Pathol. 2012 Feb; 36(2):235-41.
Score: 0.088
-
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer. 2012 May 15; 118(10):2674-81.
Score: 0.086
-
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011 Nov; 18(12):3493-9.
Score: 0.084
-
Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer). Surg Today. 2010 May; 40(5):404-10.
Score: 0.078
-
Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
Score: 0.052
-
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012 Feb; 255(2):326-33.
Score: 0.022
-
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011 Jul 20; 3(92):92ra66.
Score: 0.021
-
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011 Mar 04; 331(6021):1199-203.
Score: 0.021